pulmonary nodule News
-
Edison Shines Light on the Monarch Platform
Innovation begins when there is a need for something better. The Monarch™ Platform has been named a 2019 Edison Award finalist in the medical/dental category. The annual award competition honors excellence in new product and service development, marketing, human-centered design and innovation. Since its inception in 1987, the Edison Awards have sought to foster innovation by recognizing ...
-
Nanox and USARAD Introduce Radiology AI Second Opinion Program
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announces an extension of its strategic collaboration with USARAD Holdings Inc., a US Joint Commission accredited teleradiology and telemedicine company, to launch an advanced radiology diagnostics service combining over 300 expert radiologists and ...
-
Prof. Krestin Joins Fluidda’S Board of Directors
INTRODUCTION Gabriel Krestin received his MD from the University of Cologne, Germany where he also specialized in radiology, in 1981 and his PhD (Habilitation) in 1989. From 1990–1997, he worked at the University Hospital in Zürich/CH, including a period as acting chairman of the Department of Radiology. In 1997 he moved to Erasmus MC in Rotterdam, Netherlands where he was the ...
By Fluidda
-
Bayer expands Radiology Business into AI Market with Calantic Digital Solutions
AI applications for medical imaging can improve prioritization, lesion detection, quantification and productivity Cloud-hosted platform provides access to AI applications that integrate into standard medical imaging workflow Market introduction to start in US and several European countries Strategically complements Bayer’s comprehensive portfolio of contrast media, fluid delivery ...
By Bayer AG
-
Results and Presentation of Important New Research at the 2018 IASLC World Conference on Lung Cancer
VisionGate, a clinical stage oncology pharmaceutical and diagnostics company announces two peer-reviewed poster presentations at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (WCLC), 23-26 September in Toronto, Canada. These studies demonstrate important new morphometric detection findings of the Cell-CT™ platform and the LuCED® ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you